Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
I’m not the person you’ve been responding to. You’re not wrong that it’s hard, but it really is simple. It doesn’t have to be one or the other.
People keep comparing it to drug addiction and that’s pretty a pretty good comparison. Telling a drug addict to stop using drugs is not usually productive on its own because doing so is extremely difficult. However, quitting or severely limiting usage is still the ultimate goal of any addiction treatment plan. The steps are simple but difficult to implement.